HF
ARKG icon

HRT Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

HRT Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322K Buy
+12,200
New +$357K ﹤0.01% 2820
2025
Q4 		– Sell
-8,800
Closed -$244K – 3148
2025
Q3 		$244K Buy
+8,800
New +$222K ﹤0.01% 2307

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HRT Financial's ARKG Position: Q1 2026 in Review

HRT Financial opened a new position in ARK Genomic Revolution ETF (ARKG) in Q1 2026: 24,134 shares worth $637K. The stake represents ﹤0.01% of the portfolio and ranks #2341 among its holdings. This is a return to the name: HRT Financial previously reported a position in ARKG as recently as Q1 2025.

HRT Financial first reported a position in ARKG in Q4 2020 and has held it in 12 quarters since. The position peaked at $33.5M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • HRT Financial held 24,134 shares of ARK Genomic Revolution ETF worth $637K as of Q1 2026.
  • ARK Genomic Revolution ETF was a new HRT Financial position in Q1 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2341 holding.
  • HRT Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 12 quarters since.
  • HRT Financial's ARK Genomic Revolution ETF position peaked at $33.5M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.